Clinical trial
A Randomised, Open-label Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Naive Autoimmune Hepatitis
NCT02900443 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Open-label Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Naive Autoimmune Hepatitis
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 31, 2017
- Completion date
- June 30, 2023
- Enrollment
- 70 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune hepatitis